Patents by Inventor Takaaki Abe

Takaaki Abe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11413962
    Abstract: An in-vehicle apparatus mounted in a vehicle includes: an assistance processing unit that executes assistance processing for providing a user with specified information; and a display control unit that performs control to display a list according to a sequential order of the assistance processing executed by the assistance processing unit.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: August 16, 2022
    Assignee: Clarion Co., Ltd.
    Inventors: Norikazu Nara, Noriyuki Abe, Makoto Orino, Takaaki Yashiro, Toshihiro Mochizuki, Norimasa Kishi
  • Patent number: 11408747
    Abstract: An in-vehicle apparatus mounted in a vehicle includes: a map information storage unit that stores map information; a communication control unit that acquires traffic information; a travel history database in which a travel history of the vehicle with respect to each road is recorded; a route estimation unit that estimates a travel route of the vehicle by using the map information and the travel history database; a traveling time calculation unit that calculates actual traveling time of the vehicle with respect to the travel route and calculates predicted traveling time required when traveling the travel route estimated by the route estimation unit by using the traffic information; and a display control unit that performs control to display a map screen indicating the travel route and display the actual traveling time and the predicted traveling time together with the map screen.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: August 9, 2022
    Assignee: Clarion Co., Ltd.
    Inventors: Norikazu Nara, Noriyuki Abe, Makoto Orino, Takaaki Yashiro, Toshihiro Mochizuki, Norimasa Kishi
  • Patent number: 11369615
    Abstract: A means for substantially improving mitochondrial dysfunction is provided. An aspect of the present invention relates to an agent for improving mitochondrial dysfunction, having a compound represented by the following formula, a stereoisomer or a salt thereof, or a solvate thereof, as an active ingredient. Another aspect of the present invention relates to a medicament or a pharmaceutical composition having the aforementioned compound, a stereoisomer or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, as an active ingredient, for use in preventing or treating a disease or symptom caused by mitochondrial dysfunction.
    Type: Grant
    Filed: November 7, 2018
    Date of Patent: June 28, 2022
    Assignees: JICHI MEDICAL UNIVERSITY, TOHOKU UNIVERSITY
    Inventors: Hitoshi Osaka, Takanori Yamagata, Eriko Jimbo, Akihiko Miyauchi, Takaaki Abe
  • Publication number: 20220175724
    Abstract: An object of the present invention is to provide a low molecular weight compound having a prophylactic or therapeutic action on cancer. A compound of the following formula (1), a compound of the following formula (2), or the like can be administered by a method such as oral administration to prevent or treat cancers such as colorectal cancer.
    Type: Application
    Filed: March 25, 2020
    Publication date: June 9, 2022
    Inventors: Takaaki Abe, Shinobu Ohnuma, Michiaki Unno, Kenichiro Hayashi
  • Publication number: 20220106270
    Abstract: An object of the present invention is to provide an agent for enhancing fertilization function of a mammal sperm, which comprises a low molecular compound which can be produced relatively easily and inexpensively as an active ingredient, and a method for enhancing fertilization function of a mammal sperm and a method for preparing a mammal fertilized egg, which use a low molecular compound which can be produced relatively easily and inexpensively. An agent comprising one or more compounds selected from the group consisting of compounds of the following formula (I0), formula (II), and formula (III), and physiologically acceptable salts thereof when R3 is OH is used as an agent for enhancing fertilization function of a mammal sperm.
    Type: Application
    Filed: June 4, 2019
    Publication date: April 7, 2022
    Inventors: Takaaki Abe, Nobuo Yaegashi, Masahito Tachibana, Kenichiro Hayashi
  • Publication number: 20210366324
    Abstract: A content generation method generates image content to be projected at a projection position in a real space by a projector. In a first acquisition process, space information regarding a virtual space corresponding to the real space is acquired. In a second acquisition process, display position information regarding a display position corresponding to the projection position in the virtual space is acquired. In a third acquisition process, reference position information regarding a reference position in the virtual space is acquired. In a generation process, an image including an object viewed from the reference position when the object is displayed at the display position in the virtual space is generated as the image content, based on the space information, the reference position information, and the display position information.
    Type: Application
    Filed: May 18, 2021
    Publication date: November 25, 2021
    Inventors: Ken Mashitani, Junji Masumoto, Takaaki Abe, Akio Yamanaka
  • Patent number: 11147796
    Abstract: It is to provide an agent for preventing or improving hearing loss, which comprises a low molecular compound which can be produced relatively easily and inexpensively as an active ingredient. One or more compounds selected from the group consisting of compounds represented by the following formulas (I0), (II), and (III) and a pharmaceutically acceptable salt of the compounds when R3 is OH are used as an agent for preventing or improving hearing loss.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: October 19, 2021
    Assignees: TOHOKU UNIVERSITY, KAKE EDUCATIONAL INSTITUTION
    Inventors: Takaaki Abe, Yukio Katori, Yohei Honkura, Fumika Nanto, Kenichiro Hayashi
  • Publication number: 20210286250
    Abstract: A projection direction change device includes a mirror that reflects light emitted from a projection lens unit of a projector, a mirror support part that rotatably supports the mirror around a first axis and a second axis, a first drive part that rotary drives the mirror around the first axis, and a second drive part that rotary drives the mirror around the second axis. An intersecting point of the first and second axes is positioned closer to the projection lens unit than a geometric barycenter of the mirror is.
    Type: Application
    Filed: March 10, 2021
    Publication date: September 16, 2021
    Inventors: Takaaki ABE, Ken MASHITANI, Junji MASUMOTO
  • Patent number: 10872440
    Abstract: An image signal processing device receives image signals from source devices and outputs image signals via a plurality of communication paths. The image signal processing device includes a plurality of compression circuits, a transmission circuit and a path/compression-rate setting circuit. The plurality of compression circuits compress image signals to be transmitted via the plurality of communication paths. The transmission circuit outputs the image signals compressed. The path/compression-rate setting circuit, based on each data amount of the image signals received, determines a communication path for transmitting a part or the whole of each of the image signal, and sets a common compression rate for all of the plurality of compression circuits. The path/compression-rate setting circuit divides an image signal having a relatively large data amount, and assigns a part of the divided image signal to a communication path for transmitting an image signal having a relatively small data amount.
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: December 22, 2020
    Assignee: PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.
    Inventors: Masaru Sekizawa, Takaaki Abe, Ryoji Okubo, Kazuma Tani, Iori Hayashi
  • Patent number: 10869858
    Abstract: It is an object of the present invention to provide a novel therapeutic agent and method for treating amyotrophic diseases, and more specifically a therapeutic agent and method for treating neurogenic amyotrophic disorders such as amyotrophic lateral sclerosis (ALS) and myogenic amyotrophic disorders such as sarcopenia or disuse muscle atrophy. Provided is a therapeutic agent for amyotrophic diseases that comprises one or more compounds selected from the group consisting of compounds represented by the formula (I), the formula (II) and the formula (III), and pharmaceutically acceptable salts of the compounds when R3 represents OH.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: December 22, 2020
    Assignee: Tohoku University
    Inventors: Takaaki Abe, Masakuni Horiguchi, Yuji Matsumoto, Maiko Nagayasu, Keiichi Murakami
  • Publication number: 20200330475
    Abstract: A means for substantially improving mitochondrial dysfunction is provided. An aspect of the present invention relates to an agent for improving mitochondrial dysfunction, having a compound represented by the following formula, a stereoisomer or a salt thereof, or a solvate thereof, as an active ingredient. Another aspect of the present invention relates to a medicament or a pharmaceutical composition having the aforementioned compound, a stereoisomer or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, as an active ingredient, for use in preventing or treating a disease or symptom caused by mitochondrial dysfunction.
    Type: Application
    Filed: November 7, 2018
    Publication date: October 22, 2020
    Applicants: JICHI MEDICAL UNIVERSITY, TOHOKU UNIVERSITY
    Inventors: Hitoshi OSAKA, Takanori YAMAGATA, Eriko JIMBO, Akihiko MIYAUCHI, Takaaki ABE
  • Patent number: 10802031
    Abstract: An object of the present invention is to provide a biomarker capable of determining the onset risk or the stage of diabetic nephropathy (early-stage diabetic nephropathy in particular). Diabetic nephropathy is determined by measuring or quantitatively determining a concentration of phenyl sulfate or a salt thereof (a phenyl sulfate) contained in a biological sample, preferably plasma or urine, collected from a test subject to detect a phenyl sulfate. The present invention exhibits excellent effects particularly for stage determination for stage 1 (pre-nephropathy stage) to stage 3 (overt nephropathy stage), or for determination of onset risk of diabetic nephropathy (diabetic nephropathy at pre-nephropathy stage).
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: October 13, 2020
    Assignee: TOHOKU UNIVERSITY
    Inventors: Takaaki Abe, Susumu Ogawa, Yoshihisa Tomioka
  • Patent number: 10463647
    Abstract: The present invention provides an erythropoietin expression-enhancing agent that can cancel the suppression of erythropoietin production or promote erythropoietin production, and a therapeutic or preventive drug for anemia, a liver function-improving agent, an ischemic injury-improving agent, a renal protective agent, and an insulin secretagogue comprising the erythropoietin expression-enhancing agent. The erythropoietin expression-enhancing agent of the present invention comprises one or more compounds selected from the group consisting of compounds represented by the following general formulas (I), (II), and (III) and pharmaceutically acceptable salts thereof when R3 is OH.
    Type: Grant
    Filed: June 25, 2018
    Date of Patent: November 5, 2019
    Assignee: TOHOKU UNIVERSITY
    Inventors: Takaaki Abe, Teiji Tominaga, Kenichiro Hayashi, Hitoshi Osaka
  • Publication number: 20190224165
    Abstract: It is to provide an agent for preventing or improving hearing loss, which comprises a low molecular compound which can be produced relatively easily and inexpensively as an active ingredient. One or more compounds selected from the group consisting of compounds represented by the following formulas (I0), (II), and (III) and a pharmaceutically acceptable salt of the compounds when R3 is OH are used as an agent for preventing or improving hearing loss.
    Type: Application
    Filed: December 21, 2018
    Publication date: July 25, 2019
    Inventors: Takaaki Abe, Yukio Katori, Yohei Honkura, Fumika Nanto, Kenichiro Hayashi
  • Patent number: 10353660
    Abstract: Image display system 10 comprises: a plurality of display devices 111; an image processing unit for receiving input of a plurality of input video signals and generating an output video signal for each display device in accordance with a layout for the display devices from the input video signals; a pattern signal generation unit for generating pattern signals indicating a plurality of different test pattern images; a selector for receiving input of the output video signals and the pattern signals and selecting and outputting either the output video signals or the pattern signals; imaging device 120 for capturing an image of the test pattern images displayed on the respective display devices; and a control device 140 for analyzing the captured image captured by the imaging device and generating control information for controlling the image processing unit, based on analysis results.
    Type: Grant
    Filed: September 12, 2017
    Date of Patent: July 16, 2019
    Assignee: PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.
    Inventors: Ryoji Okubo, Ken Mashitani, Masaru Sekizawa, Takaaki Abe, Kazuma Tani
  • Publication number: 20190054066
    Abstract: It is an object of the present invention to provide a novel therapeutic agent and method for treating amyotrophic diseases, and more specifically a therapeutic agent and method for treating neurogenic amyotrophic disorders such as amyotrophic lateral sclerosis (ALS) and myogenic amyotrophic disorders such as sarcopenia or disuse muscle atrophy. Provided is a therapeutic agent for amyotrophic diseases that comprises one or more compounds selected from the group consisting of compounds represented by the formula (I), the formula (II) and the formula (III), and pharmaceutically acceptable salts of the compounds when R3 represents OH.
    Type: Application
    Filed: June 24, 2016
    Publication date: February 21, 2019
    Inventors: Takaaki ABE, Masakuni HORIGUCHI, Yuji MATSUMOTO, Maiko NAGAYASU, Keiichi MURAKAMI
  • Publication number: 20190012810
    Abstract: An image signal processing device receives image signals from source devices and outputs image signals via a plurality of communication paths. The image signal processing device includes a plurality of compression circuits, a transmission circuit and a path/compression-rate setting circuit. The plurality of compression circuits compress image signals to be transmitted via the plurality of communication paths. The transmission circuit outputs the image signals compressed. The path/compression-rate setting circuit, based on each data amount of the image signals received, determines a communication path for transmitting a part or the whole of each of the image signal, and sets a common compression rate for all of the plurality of compression circuits. The path/compression-rate setting circuit divides an image signal having a relatively large data amount, and assigns a part of the divided image signal to a communication path for transmitting an image signal having a relatively small data amount.
    Type: Application
    Filed: July 2, 2018
    Publication date: January 10, 2019
    Inventors: MASARU SEKIZAWA, TAKAAKI ABE, RYOJI OKUBO, KAZUMA TANI, IORI HAYASHI
  • Patent number: 10158848
    Abstract: A projection video display that projects video image suppresses deterioration of its quality which is attributed to a change in an optical path of the video image. A video signal generator performs control such that a second subframe in an N-th frame in a left-eye image is displayed on DMDs and then a second subframe in an N-th frame in a right-eye image is displayed on the DMDs. Furthermore, the video signal generator performs control such that a displayed location is not changed on a screen and the same types of subframes are displayed at the time when frames are switched.
    Type: Grant
    Filed: October 3, 2016
    Date of Patent: December 18, 2018
    Assignee: Panasonic Intellectual Property Management Co., Ltd.
    Inventors: Ken Mashitani, Takaaki Abe, Tamotsu Akeyama
  • Publication number: 20180353475
    Abstract: The present invention provides an erythropoietin expression-enhancing agent that can cancel the suppression of erythropoietin production or promote erythropoietin production, and a therapeutic or preventive drug for anemia, a liver function-improving agent, an ischemic injury-improving agent, a renal protective agent, and an insulin secretagogue comprising the erythropoietin expression-enhancing agent. The erythropoietin expression-enhancing agent of the present invention comprises one or more compounds selected from the group consisting of compounds represented by the following general formulas (I), (II), and (III) and pharmaceutically acceptable salts thereof when R3 is OH.
    Type: Application
    Filed: June 25, 2018
    Publication date: December 13, 2018
    Inventors: Takaaki ABE, Teiji TOMINAGA, Kenichiro HAYASHI, Hitoshi OSAKA
  • Publication number: 20180313851
    Abstract: An object of the present invention is to provide a biomarker capable of determining the onset risk or the stage of diabetic nephropathy (early-stage diabetic nephropathy in particular). Diabetic nephropathy is determined by measuring or quantitatively determining a concentration of phenyl sulfate or a salt thereof (a phenyl sulfate) contained in a biological sample, preferably plasma or urine, collected from a test subject to detect a phenyl sulfate. The present invention exhibits excellent effects particularly for stage determination for stage 1 (pre-nephropathy stage) to stage 3 (overt nephropathy stage), or for determination of onset risk of diabetic nephropathy (diabetic nephropathy at pre-nephropathy stage).
    Type: Application
    Filed: September 29, 2016
    Publication date: November 1, 2018
    Inventors: Takaaki ABE, Susumu OGAWA, Yoshihisa TOMIOKA